Drug Shortage Report for PULMOPHYLLINE ELX
| Report ID | 1652 |
| Drug Identification Number | 00466409 |
| Brand name | PULMOPHYLLINE ELX |
| Common or Proper name | Theophylline oral solution USP |
| Company Name | LABORATOIRE RIVA INC |
| Market Status | DORMANT |
| Active Ingredient(s) | THEOPHYLLINE |
| Strength(s) | 80MG |
| Dosage form(s) | ELIXIR |
| Route of administration | ORAL |
| Packaging size | 1 |
| Anatomical Therapeutical Chemical (ATC) code | R03DA |
| Anatomical Therapeutical Chemical (ATC) description | OTHER SYSTEMIC DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES |
| Reason for shortage | Disruption of the manufacture of the drug. |
| Anticipated start date | 2014-04-11 |
| Actual start date | 2014-04-11 |
| Estimated end date | Unknown |
| Actual end date | |
| Shortage status | Actual shortage |
| Updated date | 2026-03-17 |
| Company comments | |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 660 BOUL. INDUSTRIEL BLAINVILLE, QUEBEC CANADA J7C 3V4 |
| Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v3 | 2017-03-13 | French | Compare |
| v2 | 2017-03-13 | English | Compare |
| v1 | 2017-03-13 | English | Compare |
Showing 1 to 3 of 3